Ultrasound Screening for Developmental Dysplasia of the Hip in Newborns

Status Completed

Clinical Trial Summary

The aim of the randomized controlled trial was to determine whether the addition of a general or of a selective ultrasound screening program resulted in more appropriate criteria for treatment and a reduced prevalence of late DDH compared with clinical examination alone.

Clinical Trial Description

This is a retrospective registration of a RCT carried out in 1988-90, with a IRB approved follow-up at skeletal maturity carried out in 2007-09. Both the RCT and the follow-up study were carried out in the same institution, by the same PI (Prof. Karen Rosendahl) and her co-workers.

Detailed information is published in the following paper:

Rosendahl K, Markestad T, Lie RT. Ultrasound screening for developmental dysplasia of the hip in the neonate: the effect on treatment rate and prevalence of late cases. Pediatrics 1994;94:47-52.

A sample of the initial RCT was invited for a maturity review/follow-up at skeletal maturity.

The follow-up at skeletal maturity is called:

Radiological indices of hip dysplasia and osteoarthritis at skeletal maturity in the Bergen Birth Cohort. Associations with neonatal hip dysplasia, childhood growth and genetic predisposition

and is included in the approval by the Regional Ethical Committee for Medical and Health Research (No 3.2006.144). All participants of the follow-up study gave written informed consent according to the 1964 Declaration of Helsinki.

The follow-up had the following main aims:

1) estimate the prevalence of radiologically defined hip dysplasia, femoroacetabular impingement and osteoarthritis assessed at skeletal maturity 2)report the frequency of 4 longitudinal dysplasia phenotypes based on sonographic assessments in the newborn and radiological assessments at skeletal maturity 3)investigate associations of dysplasia as defined in 1 and 2 above in univariate and multivariate models with clinically assessed hip joint mobility/joint hypermobility, weight, height and body mass index (BMI) at age 18/19 years, prepubertal weight, height and BMI trajectories using data from child health records, first degree family history of hip dysplasia with or without hip arthroplasty, perinatal factors, measures of OA including minimum joint space, acetabular depth ratio and reported hip pain 5) establish a genetic resource by obtaining and archiving salivary DNA samples. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01818934
Study type	Interventional
Source	University of Bergen
Contact
Status	Completed
Phase	N/A
Start date	January 1988
Completion date	March 2009

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05543109` - Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block	N/A
Active, not recruiting	`NCT03326804` - H1 Hip Resurfacing Arthroplasty
Active, not recruiting	`NCT05142462` - Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup
Recruiting	`NCT03109444` - Normative Radiographic Parameters and Growth Curve of Hips Less Than Six Weeks of Gestational Age Using Ultrasound
Withdrawn	`NCT02259140` - A Randomized Control Trial of Hip Dislocation Techniques for Pediatric Patients With Cerebral Palsy	N/A
Completed	`NCT06087549` - PENG Block vs. ESP Block for Pediatric Hip Surgery	Phase 4
Completed	`NCT03874936` - The Effect of Perioperative Dexamethasone Administration on Postoperative Pain in Patients Undergoing Periacetabular Osteotomy.	Phase 2/Phase 3
Active, not recruiting	`NCT04943328` - Cemented TrendHip® - Multicenter PMCF Study on Total Indications	N/A
Not yet recruiting	`NCT04157842` - The Influence of Hip Replacement on Lower Extremity Hemodynamics in Crowe IV Hip Dysplasia Patient	N/A
Active, not recruiting	`NCT04995822` - Post Market Clinical Follow-up of EUROSTEM Femoral Stem
Recruiting	`NCT05687955` - Exercise Rehabilitation for Hip-related Pain and Dysfunction in Student Circus Arts Performers	N/A
Completed	`NCT01344421` - Movement Pattern in Patients With Hip Dysplasia	N/A
Recruiting	`NCT05366712` - Nexus Evaluation Primary Trident II Uncemented Shell	N/A
Recruiting	`NCT04993638` - Post Market Clinical Follow-up of Dual-mobility Acetabular Cup EUROSCUP MOBILE
Completed	`NCT04591067` - Physical Capacity Among Patients Treated With Periacetabular Osteotomy for Hip Dysplasia: a Cross-sectional Study
Withdrawn	`NCT03530878` - Mild Hip Dysplasia	N/A
Not yet recruiting	`NCT03193385` - Treatment of Developmental Dysplasia of the HIp	N/A
Not yet recruiting	`NCT05921721` - Can EOS Hip Imaging Replace CT Hip Scans?	N/A
Active, not recruiting	`NCT03941171` - Is Periacetabular Osteotomy Superior to Progressive Resistance Training?	N/A
Recruiting	`NCT05361980` - Pediatric Orthopaedic Implant Safety & Efficacy

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.